Clinical trial
Investigation "in Vitro" of New Strategies Alternative to Surgery Against Cutaneous Squamous Cell Carcinoma: Topical Chemotherapy Followed by Superficial Radiotherapy.
NCT02672254 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation "in Vitro" of New Strategies Alternative to Surgery Against Cutaneous Squamous Cell Carcinoma: Topical Chemotherapy Followed by Superficial Radiotherapy.
- Lead sponsor
- Corporacion Parc Tauli
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- January 31, 2016
- Enrollment
- 3 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.